Rossari Biotech Ltd consolidated Q1FY23 profit climbs to Rs. 28.68 crores

Rossari Biotech Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 435.454 crores during the period ended June 30, 2022 as compared to Rs. 440.904 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 28.681 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 24.081 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 5.18 for the period ended June 30, 2022 as compared to Rs. 4.35 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 435.454 crs	₹440.904 crs	-1.24%
Net Profit	₹28.681 crs	₹24.081 crs	19.10%
EPS	₹5.18	₹4.35	19.08%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 435.454 crores during the period ended June 30, 2022 as compared to Rs.233.442 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.28.681 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.24.522 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.5.18 for the period ended June 30, 2022 as compared to Rs.4.49 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 435.454 crs	₹233.442 crs	86.54%
Net Profit	₹28.681 crs	₹24.522 crs	16.96%
EPS	₹5.18	₹4.49	15.37%

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 947.65 as compared to the previous close of Rs. 938.75. The total number of shares traded during the day was 5356 in over 1142 trades.

The stock hit an intraday high of Rs. 969.20 and intraday low of 928.25. The net turnover during the day was Rs. 5070503.00.

Source : Equity Bulls

Keywords

RossariBiotech Q1FY23 ResultUpdate